CD14 and apoptosis

Apoptosis

Volumn 4, Issue 1, 1999, Pages 11-20

  Gregory, C D ^a   Devitt, A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adhesion; Inflammation; Lipopolysaccharide; Macrophage; Phagocytosis; Signalling

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL ADHESION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; INFLAMMATION; LIGAND BINDING; MACROPHAGE ACTIVATION; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW;

BACTERIA (MICROORGANISMS);

EID: 0032767781     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009673914340     Document Type: Review

References (78)

1. Wright SD, Ramos RA, Tobias PS, Ulevitch, RJ Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
2. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Ann Rev Immunol 1995; 13: 437-457.
3. Beekhuizen H, Blokland I, Corselvantilburg AJ, Koning F, Vanfurth R. CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol 1991; 147: 3761-3767.
4. Lue KH, Lauener RP, Winchester RJ, Geha RS, Vercelli D. Engagement of CD14 on human monocytes terminates T-cell proliferation by delivering a negative signal to T cells. J Immunol 1991; 147: 1134-1138.
5. Jabara HH, Vercelli D. Engagement of CD14 on monocytes inhibits the synthesis of human Igs, including IgE. J Immunol 1994; 153: 972-978.
6. Haziot A, et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407-414.
7. Devitt A, et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392: 505-509.
8. Heidenreich S, et al. Regulation of human monocy te apoptosis by the CD14 molecule .J Immunol 1997; 159: 3178-3188.
9. Frey EA, Finlay BB. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway. Microbial Pathogenesis 1998; 24: 101-109.
10. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 1981; 68: 932-941.
11. Todd RF, Nadler LM, Schlossman SF. Antigens on human-monocytes identified by monoclonal antibodies. J Immunol 1981; 126: 1435-1442.
12. Goyert SM, et al. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239: 497-500.
13. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 1989; 73: 284-289.
14. Gadd S. In: Knapp W, ed. Leukocyte Typing IV White Cell Differentiation Antigens. Oxford, UK: Oxford University Press, 1989: 787-789.
15. Ziegler-Heitbrock HWL, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993; 14: 121-125.
16. Guilbert L, Robertson SA, Wegmann TG. The trophoblast as an integral component of a macrophage cytokine network. Immunol Cell Biology 1993; 71: 49-57.
17. Hailman E, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exper Med 1994; 179: 269-277.
18. Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high-density lipoprotein. J Exper Med 1995; 181: 1743-1754.
19. Wurfel MM, Wright SD. Lipopolysaccharide binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers - preferential interaction with particular classes of lipid. J Immunol 1997; 158: 3925-3934.
20. Yu B, Hailman E, Wright SD. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 1997; 99: 315-324.
21. Petty HR, Todd RF. Integrins as promiscuous signal transduction devices. Immunol Today 1996; 17: 209-212.
22. Joseph CK, et al. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J Biolog Chem 1994; 269: 17606-17610.
23. Thieblemont N, Thieringer R, Wright SD. Innate immune recognition of bacterial lipopolysaccharide: dependence on interactions with membrane lipids and endocytic movement. Immunity 1998; 8: 771-777.
24. Lee JD, et al. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Nat Acad Sci USA 1993; 90: 9930-9934.
25. Yang R-B, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284-288.
26. Vita N, et al. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. J Immunol 1997; 158: 3457-3462.
27. Juan TSC, Hailman E, Kelley MJ, Wright SD, Lichenstein HS. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J Biolog Chem 1995; 270: 17237-17242.
28. Stelter F, et al. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Euro J Biochem 1997; 243: 100-109.
29. Juan TSC, et al. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biolog Chem 1995; 270: 5219-5224.
30. McGinley MD, et al. CD14-physical properties and identification of an exposed site that is protected by lipopolysaccharide. J Biolog Chem 1995; 270: 5213-5218.
31. Pugin J, et al. CD14 is a pattern recognition receptor. Immunity 1994; 1: 509-516.
32. Medzhitov R, Janeway CA. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997; 91: 295-298.
33. Kitchens RL, Ulevitch RJ, Munford RS. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exper Med 1992; 176: 485-494.
34. Kitchens RL, Munford RS. Enzymatically deacylated lipopolysacchande (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biolog Chem 1995; 270: 9904-9910.
35. Savedra R, Delude RL, Ingalls RR, Fenton MJ, Golenbock DT. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J Immunol 1996; 157: 2549-2554.
36. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-305.
37. Savill J. Phagocyte recognition of apoptotic cells. Biochem Soc Trans 1996; 24: 1065-1069.
38. Ren Y, Savill J. Apoptosis: The importance of being eaten. Cell Death Diff 1998; 5: 563-568.
39. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Diff 1998; 5: 551-562.
40. Savill J. Apoptosis - Phagocytic docking without shocking. Nature 1998; 392: 442-443.
41. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343: 170-173.
42. Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992; 90: 1513-1522.
43. Luciani M-F, Chimini G. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J 1996; 15: 226-235.
44. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Nat Acad Sci USA 1996; 93: 12456-12460.
45. Ellis RE, Jacobson DM, Horvitz HR. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans. Genetics 1991; 129: 79-94.
46. Wu YC, Horvitz HR. The C. elegans cell corpse engulfment gene ced-7 encodes a protein similar to ABC transporters. Cell 1998; 93: 951-960.
47. Wu YC, Horvitz HR. C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180. Nature 1998; 392: 501-504.
48. Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunol 1985; 56: 351-358.
49. Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett 1992; 296: 174-178.
50. Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J Immunol 1994; 153: 3218-3227.
51. Fadok VA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.
52. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exper Med 1995; 182: 1597-1601.
53. Koopman G, et al. Annexin-V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-1420.
54. Stern M, Savill J, Haslett C. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis - mediation by alpha(v)beta(3)/cd36/ thrombospondin recognition mechanism and lack of phlogistic response. Amer J Pathol 1996; 149: 911-921.
55. Voll RE, et al. Immunosuppressive effects of apoptotic cells. Nature 1997; 390: 350-351.
56. Fadok VA, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
57. Flora PK, Gregory CD. Recognition of apoptotic cells by human macrophages - inhibition by a monocyte/macrophage-specific monoclonal antibody. Euro J Immunol 1994; 24: 2025-2632.
58. Pradhan D, Krahling S, Williamson P, Schlegel RA. Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell 1997; 8: 767-778.
59. Fadok VA, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 4029-4035.
60. Flora PK, Gregory CD. In: Schlossman SF, ed. Leucocyte Typing V. White Cell Differentiation Antigens. Oxford, UK: Oxford University Press, 1995: 1675-1677.
61. Flora PK, Devitt A, Johnson GD, Milner AE, Gregory CD. Bcl-2 delays macrophage engulfment of human B cells induced to undergo apoptosis. Euro J Immunol 1996; 26: 2243-2247.
62. Devitt A, Pierce S, Moffatt OD, Gregory CD. Role of human macrophage CD14 in clearance of apoptotic cells: lack of involvement of phosphatidylserine. 1998 (submitted).
63. Moffatt OD, Devitt A, Bell ED, Simmons DL, Gregory CD. Macrophage recognition of ICAM-3 on apoptotic leukocytes. J Immunol 1999 (in press).
64. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs. Nature 1998; 392: 86-89.
65. Austyn JM. Dendritic cells. Curr Opin Hematol 1998; 5: 3-15.
66. Wooten RM, et al. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol 1998; 160: 5485-5492.
67. Weidemann B, et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun 1994; 62: 4709-4715.
68. Gupta D, Jin YP, Dziarski R. Peptidoglycan induces transcription and secretion of TNF-alpha and activation of lyn, extracellular signal-regulated kinase, and rsk signal-transduction proteins in mouse macrophages. J Immunol 1995; 155: 2620-2630.
69. Gupta D, Kirkland TN, Viriyakosol S, Dziarski R. CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biolog Chem 1996; 271: 23310-23316.
70. Weidemann B, et al. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun 1997; 65: 858-864.
71. Dziarski R, Tapping RI, Tobias PS. Binding of bacterial peptidoglycan to CD14. J Biolog Chem 1998; 273: 8680-8690.
72. Espevik T, et al. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Euro J Immunol 1993; 23: 255-201.
73. Zhang YH, Doerfler M, Lee TC, Guillemin B, Rom WN. Mechanisms of stimulation of interleukin-1-beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest 1993; 91: 2076-2083.
74. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996; 64: 1906-1912.
75. Kusunoki T, Hailman E, Juan TSC, Lichenstein HS, Wright SD. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exper Med 1995; 182: 1673-1682.
76. Hmama Z, Mey A, Normier G, Binz H, Revillard JP. CD14 and CD11b mediate serum-independent binding to human monocytes of an acylpolygalactoside isolated from Klebsiella pneumoniae. Infect Immun 1994; 62: 1520-1527.
77. Soell M, et al. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan-binding protein inhibits TNF-alpha release. J Immunol 1995; 154: 851-860.
78. Cavaillon JM, et al. CD14/LPS receptor exhibits lectin-like properties. J Endotoxin Res 1996; 3: 471-480.